Model construction and clinical therapeutic potential of engineered cardiac organoids for cardiovascular diseases.
Yongtao Wang(Massachusetts General Hospital), Junjie Xiao(Shanghai University), Dragoş Crețoiu(Carol Davila University of Medicine and Pharmacy), Guoping Li(Fujian Medical University), Yan Hou(Shanghai University), Hao Tian(Massachusetts General Hospital), Marta García-Contreras(University Hospital Regensburg)
Cited by 5
Related Papers
Circular RNAs: Promising Biomarkers for Human Diseases
|EBioMedicine|2018|823
miR-29b contributes to multiple types of muscle atrophy
|Nature Communications|2017|245
Pharmacokinetics and biodistribution of extracellular vesicles administered intravenously and intranasally to <i>Macaca nemestrina</i>
|Journal of Extracellular Biology|2022|186
Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes
|Scientific Reports|2017|179
Irisin ameliorates age‐associated sarcopenia and metabolic dysfunction
|Journal of Cachexia Sarcopenia and Muscle|2022|156